Clinical Trials

Information and insight on the latest clinical trials
Rozanolixizumab to Treat Immune Thrombocytopenia

Rozanolixizumab to Treat Immune Thrombocytopenia

Tadeusz Robak, MD of the Poznań University of Medical Sciences in Poland provides a summary of a phase II clinical trial assessing rozanolixizumab for treat people with primary immune thrombocytopenia.

Clinical Trials and Rare Diseases

Clinical Trials and Rare Diseases

Timothy Craig, DO of the Penn State Milton S. Hershey Medical Center talks about the need for clinicians to be educated about the pros and cons of entering a clinical trial.

{!{wpv-view name=’pb-clinical-trials-list’ orderby=’date’ order=’desc’}!}

  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.